259 related articles for article (PubMed ID: 23746544)
1. A new mutation of the fukutin gene causing late-onset limb girdle muscular dystrophy.
Riisager M; Duno M; Hansen FJ; Krag TO; Vissing CR; Vissing J
Neuromuscul Disord; 2013 Jul; 23(7):562-7. PubMed ID: 23746544
[TBL] [Abstract][Full Text] [Related]
2. [Fukuyama congenital muscular dystrophy and related alpha-dystroglycanopathies].
Murakami T; Nishino I
Brain Nerve; 2008 Oct; 60(10):1159-64. PubMed ID: 18975603
[TBL] [Abstract][Full Text] [Related]
3. Further evidence of Fukutin mutations as a cause of childhood onset limb-girdle muscular dystrophy without mental retardation.
Puckett RL; Moore SA; Winder TL; Willer T; Romansky SG; Covault KK; Campbell KP; Abdenur JE
Neuromuscul Disord; 2009 May; 19(5):352-6. PubMed ID: 19342235
[TBL] [Abstract][Full Text] [Related]
4. Expanding the phenotype of GMPPB mutations.
Cabrera-Serrano M; Ghaoui R; Ravenscroft G; Johnsen RD; Davis MR; Corbett A; Reddel S; Sue CM; Liang C; Waddell LB; Kaur S; Lek M; North KN; MacArthur DG; Lamont PJ; Clarke NF; Laing NG
Brain; 2015 Apr; 138(Pt 4):836-44. PubMed ID: 25681410
[TBL] [Abstract][Full Text] [Related]
5. Fukutin mutations in non-Japanese patients with congenital muscular dystrophy: less severe mutations predominate in patients with a non-Walker-Warburg phenotype.
Yis U; Uyanik G; Heck PB; Smitka M; Nobel H; Ebinger F; Dirik E; Feng L; Kurul SH; Brocke K; Unalp A; Özer E; Cakmakci H; Sewry C; Cirak S; Muntoni F; Hehr U; Morris-Rosendahl DJ
Neuromuscul Disord; 2011 Jan; 21(1):20-30. PubMed ID: 20961758
[TBL] [Abstract][Full Text] [Related]
6. Fukutin gene mutations in steroid-responsive limb girdle muscular dystrophy.
Godfrey C; Escolar D; Brockington M; Clement EM; Mein R; Jimenez-Mallebrera C; Torelli S; Feng L; Brown SC; Sewry CA; Rutherford M; Shapira Y; Abbs S; Muntoni F
Ann Neurol; 2006 Nov; 60(5):603-610. PubMed ID: 17044012
[TBL] [Abstract][Full Text] [Related]
7. Clinical and molecular characterization of patients with limb-girdle muscular dystrophy type 2I.
Boito CA; Melacini P; Vianello A; Prandini P; Gavassini BF; Bagattin A; Siciliano G; Angelini C; Pegoraro E
Arch Neurol; 2005 Dec; 62(12):1894-9. PubMed ID: 16344347
[TBL] [Abstract][Full Text] [Related]
8. A homozygous DPM3 mutation in a patient with alpha-dystroglycan-related limb girdle muscular dystrophy.
Van den Bergh PYK; Sznajer Y; Van Parys V; van Tol W; Wevers RA; Lefeber DJ; Xu L; Lek M; MacArthur DG; Johnson K; Phillips L; Töpf A; Straub V
Neuromuscul Disord; 2017 Nov; 27(11):1043-1046. PubMed ID: 28803818
[TBL] [Abstract][Full Text] [Related]
9. Novel ANO5 mutations causing hyper-CK-emia, limb girdle muscular weakness and Miyoshi type of muscular dystrophy.
Schessl J; Kress W; Schoser B
Muscle Nerve; 2012 May; 45(5):740-2. PubMed ID: 22499103
[TBL] [Abstract][Full Text] [Related]
10. Eight new mutations and the expanding phenotype variability in muscular dystrophy caused by ANO5.
Penttilä S; Palmio J; Suominen T; Raheem O; Evilä A; Muelas Gomez N; Tasca G; Waddell LB; Clarke NF; Barboi A; Hackman P; Udd B
Neurology; 2012 Mar; 78(12):897-903. PubMed ID: 22402862
[TBL] [Abstract][Full Text] [Related]
11. A novel FKRP gene mutation in a Taiwanese patient with limb-girdle muscular dystrophy 2I.
Lin YC; Murakami T; Hayashi YK; Nishino I; Nonaka I; Yuo CY; Jong YJ
Brain Dev; 2007 May; 29(4):234-8. PubMed ID: 17055682
[TBL] [Abstract][Full Text] [Related]
12. Fukutin mutations in congenital muscular dystrophies with defective glycosylation of dystroglycan in Korea.
Lim BC; Ki CS; Kim JW; Cho A; Kim MJ; Hwang H; Kim KJ; Hwang YS; Park WY; Lim YJ; Kim IO; Lee JS; Chae JH
Neuromuscul Disord; 2010 Aug; 20(8):524-30. PubMed ID: 20620061
[TBL] [Abstract][Full Text] [Related]
13. Limb girdle muscular dystrophy type 2I: No correlation between clinical severity, histopathology and glycosylated α-dystroglycan levels in patients homozygous for common FKRP mutation.
Alhamidi M; Brox V; Stensland E; Liset M; Lindal S; Nilssen Ø
Neuromuscul Disord; 2017 Jul; 27(7):619-626. PubMed ID: 28479227
[TBL] [Abstract][Full Text] [Related]
14. Fukutin gene mutations cause dilated cardiomyopathy with minimal muscle weakness.
Murakami T; Hayashi YK; Noguchi S; Ogawa M; Nonaka I; Tanabe Y; Ogino M; Takada F; Eriguchi M; Kotooka N; Campbell KP; Osawa M; Nishino I
Ann Neurol; 2006 Nov; 60(5):597-602. PubMed ID: 17036286
[TBL] [Abstract][Full Text] [Related]
15. The limb-girdle muscular dystrophies.
Wicklund MP; Kissel JT
Neurol Clin; 2014 Aug; 32(3):729-49, ix. PubMed ID: 25037088
[TBL] [Abstract][Full Text] [Related]
16. Prevalence, mutation spectrum and phenotypic variability in Norwegian patients with Limb Girdle Muscular Dystrophy 2I.
Stensland E; Lindal S; Jonsrud C; Torbergsen T; Bindoff LA; Rasmussen M; Dahl A; Thyssen F; Nilssen Ø
Neuromuscul Disord; 2011 Jan; 21(1):41-6. PubMed ID: 20961759
[TBL] [Abstract][Full Text] [Related]
17. Four Caucasian patients with mutations in the fukutin gene and variable clinical phenotype.
Vuillaumier-Barrot S; Quijano-Roy S; Bouchet-Seraphin C; Maugenre S; Peudenier S; Van den Bergh P; Marcorelles P; Avila-Smirnow D; Chelbi M; Romero NB; Carlier RY; Estournet B; Guicheney P; Seta N
Neuromuscul Disord; 2009 Mar; 19(3):182-8. PubMed ID: 19179078
[TBL] [Abstract][Full Text] [Related]
18. Late-onset limb-girdle muscular dystrophy caused by GMPPB mutations.
Balcin H; Palmio J; Penttilä S; Nennesmo I; Lindfors M; Solders G; Udd B
Neuromuscul Disord; 2017 Jul; 27(7):627-630. PubMed ID: 28478914
[TBL] [Abstract][Full Text] [Related]
19. Inflammation and response to steroid treatment in limb-girdle muscular dystrophy 2I.
Darin N; Kroksmark AK; Ahlander AC; Moslemi AR; Oldfors A; Tulinius M
Eur J Paediatr Neurol; 2007 Nov; 11(6):353-7. PubMed ID: 17446099
[TBL] [Abstract][Full Text] [Related]
20. [A case of limb-girdle muscular dystrophy 2M diagnosed by the occurence of dilated cardiomyopathy].
Matsui M; Endo T; Matsumura T; Saito T; Fujimura H
Rinsho Shinkeigaku; 2015; 55(8):585-8. PubMed ID: 26050665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
